16
Apr
Apr
Roche Hopefull for US Approval of Actemra
Roche have filed licence applications for treatment of rheumatoid arthritis in the USA and the European Union with their innovative arthritis treatment drug, Actemra (tocilizumab).
The product is already available in Japan for patients with a rare auto-immume condition known as Castleman’s disease and following sucessfull clinical trials has now been approved for treatment there of [...]
